{"id":"https://genegraph.clinicalgenome.org/r/a759f613-6a0b-4769-93df-5cf3fc22c4cev2.2","type":"EvidenceStrengthAssertion","dc:description":"The *PPP2R5D* gene encodes the B56δ regulatory subunit of protein phosphatase 2A (PP2A), an intracellular serine/threonine phosphatase. *PPP2R5D* was first reported in relation to autosomal dominant complex neurodevelopmental disorder in 2015 (Deciphering Developmental Disorders Study, PMID: 25533962). The disorder is characterized by hypotonia, developmental delay, mild to severe intellectual disability, speech impairment, and macrocephaly. Other features present in some individuals include autism spectrum disorder, seizures, ophthalmologic abnormalities, mild dysmorphic facial features, brain MRI abnormalities, and early-onset parkinsonism.\n\nSeven missense variants that have been reported in 21 probands in four publications (PMIDs: 25533962, 25972378, 26168268, 26576547) are included in this curation. Most variants are *de novo*, and three are recurrent, with p.Glu198Lys present in 10 unrelated individuals and p.Glu200Lys present in four. Most of the reported variants cluster in a highly conserved acidic loop of the protein that faces the PP2A A and C subunits, and exhibit A and C binding defects, disrupting B56δ-dependent dephosphorylation dynamics (PMIDs: 26168268, 36216457). More evidence is available in the literature, but the maximum score for genetic evidence (12 points) has been reached. The mechanism of pathogenicity is reported to be dominant negative.\n\nThis gene-disease relationship is also supported by experimental evidence, including protein interaction and biochemical function. Pathogenic variants in other members of the protein phosphatase 2A gene family, *PPP2R1A*, *PPP2CA* and *PPP2R5C*, also cause neurodevelopmental disorders with overlapping phenotypes.\n\nIn summary, there is definitive evidence to support the relationship between *PPP2R5D* and autosomal dominant complex neurodevelopmental disorder. This has been repeatedly demonstrated in both the research and clinical diagnostic settings, and has been upheld over time. This gene-disease pair was originally evaluated by the ClinGen Intellectual Disability and Autism Gene Curation Expert Panel on August 26, 2021. It was reevaluated on April 16, 2025 (SOP Version 11). Although new experimental evidence was added, the classification did not change.\n","dc:isVersionOf":"https://genegraph.clinicalgenome.org/r/a759f613-6a0b-4769-93df-5cf3fc22c4ce","GCISnapshot":"https://genegraph.clinicalgenome.org/r/4b43ff91-1ea4-475b-97d9-6fbda924ea16","calculatedEvidenceStrength":"Definitive","changes":{"id":"cg:otherTextChange"},"contributions":[{"id":"https://genegraph.clinicalgenome.org/r/4b43ff91-1ea4-475b-97d9-6fbda924ea16_publish_contrib","agent":"https://genegraph.clinicalgenome.org/agent/10006","date":"2025-10-07T10:39:52.265Z","role":"Publisher"},{"id":"https://genegraph.clinicalgenome.org/r/4b43ff91-1ea4-475b-97d9-6fbda924ea16_contrib","agent":"https://genegraph.clinicalgenome.org/agent/10006","date":"2025-04-16T10:00:00.000Z","role":"Approver"}],"curationReasons":["ErrorClarification"],"evidence":[{"id":"https://genegraph.clinicalgenome.org/r/4b43ff91-1ea4-475b-97d9-6fbda924ea16_overall_genetic_evidence_line","type":"EvidenceLine","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/3f068465-675d-4718-818e-1822e2aa293d","type":"EvidenceLine","calculatedScore":1,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/3f068465-675d-4718-818e-1822e2aa293d_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/26576547","allele":{"id":"https://genegraph.clinicalgenome.org/r/90db29e3-cd1c-4f51-bf78-2194efc10d03","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_006245.4(PPP2R5D):c.1258G>A (p.Glu420Lys)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA325483"}},"alleleOrigin":{"id":"cg:DeNovoAlleleOrigin"},"paternityMaternityConfirmed":"Yes","zygosity":{"id":"cg:Heterozygous"}},{"id":"https://genegraph.clinicalgenome.org/r/3f068465-675d-4718-818e-1822e2aa293d_function_evidence_item","type":"VariantFunctionalImpactEvidence","dc:description":"Functional analysis in transfected HEK293 cells revealed decreased substrate binding to liprin-α1 (encoded by PPFIA1), with normal binding to PP2A A and C subunits (Oyama et al., 2023, PMID: 36216457).","functionalDataSupport":"Yes"}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":1},{"id":"https://genegraph.clinicalgenome.org/r/d7d12cbc-5706-4d80-b7aa-3e71f4711871","type":"EvidenceLine","dc:description":"Patient also reported in Houge et al. (2015, PMID: 26168268) as Case 4. ","calculatedScore":1,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/d7d12cbc-5706-4d80-b7aa-3e71f4711871_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/25533962","allele":{"id":"https://genegraph.clinicalgenome.org/r/b1dd1f45-553f-425b-a720-36f6adf69227","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_006245.4(PPP2R5D):c.592G>A (p.Glu198Lys)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA325481"}},"alleleOrigin":{"id":"cg:DeNovoAlleleOrigin"},"paternityMaternityConfirmed":"Yes","zygosity":{"id":"cg:Heterozygous"}},{"id":"https://genegraph.clinicalgenome.org/r/d7d12cbc-5706-4d80-b7aa-3e71f4711871_function_evidence_item","type":"VariantFunctionalImpactEvidence","dc:description":"Functional analysis in transfected HEK293 cells revealed impaired PP2A A and C subunit binding (Houge et al., 2015, PMID: 26168268; Oyama et al., 2023, PMID: 36216457).","functionalDataSupport":"Yes"}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":1},{"id":"https://genegraph.clinicalgenome.org/r/c3caf2ea-32a3-41ad-bb29-9f06ba0dedfa","type":"EvidenceLine","calculatedScore":1,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/c3caf2ea-32a3-41ad-bb29-9f06ba0dedfa_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/26576547","allele":{"id":"https://genegraph.clinicalgenome.org/r/b1dd1f45-553f-425b-a720-36f6adf69227"},"alleleOrigin":{"id":"cg:DeNovoAlleleOrigin"},"paternityMaternityConfirmed":"Yes","zygosity":{"id":"cg:Heterozygous"}},{"id":"https://genegraph.clinicalgenome.org/r/c3caf2ea-32a3-41ad-bb29-9f06ba0dedfa_function_evidence_item","type":"VariantFunctionalImpactEvidence","dc:description":"Functional analysis in transfected HEK293 cells revealed impaired PP2A A and C subunit binding (Houge et al., 2015, PMID: 26168268; Oyama et al., 2023, PMID: 36216457).","functionalDataSupport":"Yes"}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":1},{"id":"https://genegraph.clinicalgenome.org/r/77d86b7d-855b-44bc-a718-c42a79e55f17","type":"EvidenceLine","calculatedScore":1,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/77d86b7d-855b-44bc-a718-c42a79e55f17_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/26168268","allele":{"id":"https://genegraph.clinicalgenome.org/r/3ca8b8ff-3597-4cd4-9191-2e00a9ec228e","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_006245.4(PPP2R5D):c.598G>A (p.Glu200Lys)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA325480"}},"alleleOrigin":{"id":"cg:DeNovoAlleleOrigin"},"paternityMaternityConfirmed":"Yes","zygosity":{"id":"cg:Heterozygous"}},{"id":"https://genegraph.clinicalgenome.org/r/77d86b7d-855b-44bc-a718-c42a79e55f17_function_evidence_item","type":"VariantFunctionalImpactEvidence","dc:description":"Functional analysis in transfected HEK293 cells revealed impaired PP2A A and C subunit binding, and decreased substrate binding to liprin-α1 (encoded by PPFIA1) (Houge et al., 2015, PMID: 26168268; Oyama et al., 2023, PMID: 36216457).)","functionalDataSupport":"Yes"}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":1},{"id":"https://genegraph.clinicalgenome.org/r/c9200383-a92f-4b11-9585-53f8cf27a390","type":"EvidenceLine","calculatedScore":1,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/c9200383-a92f-4b11-9585-53f8cf27a390_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/26576547","allele":{"id":"https://genegraph.clinicalgenome.org/r/90db29e3-cd1c-4f51-bf78-2194efc10d03"},"alleleOrigin":{"id":"cg:DeNovoAlleleOrigin"},"paternityMaternityConfirmed":"Yes","zygosity":{"id":"cg:Heterozygous"}},{"id":"https://genegraph.clinicalgenome.org/r/c9200383-a92f-4b11-9585-53f8cf27a390_function_evidence_item","type":"VariantFunctionalImpactEvidence","dc:description":"Functional analysis in transfected HEK293 cells revealed decreased substrate binding to liprin-α1 (encoded by PPFIA1), with normal binding to PP2A A and C subunits (Oyama et al., 2023, PMID: 36216457).","functionalDataSupport":"Yes"}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":1},{"id":"https://genegraph.clinicalgenome.org/r/7cfa5278-b58d-4460-a39b-3a5287bc7ea4","type":"EvidenceLine","dc:description":"Patient also reported in Houge et al. (2015, PMID: 26168268) as Case 5.","calculatedScore":1,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/7cfa5278-b58d-4460-a39b-3a5287bc7ea4_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/25533962","allele":{"id":"https://genegraph.clinicalgenome.org/r/b1dd1f45-553f-425b-a720-36f6adf69227"},"alleleOrigin":{"id":"cg:DeNovoAlleleOrigin"},"paternityMaternityConfirmed":"Yes","zygosity":{"id":"cg:Heterozygous"}},{"id":"https://genegraph.clinicalgenome.org/r/7cfa5278-b58d-4460-a39b-3a5287bc7ea4_function_evidence_item","type":"VariantFunctionalImpactEvidence","dc:description":"Functional analysis in transfected HEK293 cells revealed impaired PP2A A and C subunit binding (Houge et al., 2015, PMID: 26168268; Oyama et al., 2023, PMID: 36216457). Overexpression of the E198K B56δ mutant in HEK293 cells resulted in increased phosphorylation of GSK-3β Ser9, an established PP2A-B56δ substrate in this cell line, indicating that the variant disrupts B56δ-dependent dephosphorylation (Houge et al., 2015, PMID: 26168268).","functionalDataSupport":"Yes"}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":1},{"id":"https://genegraph.clinicalgenome.org/r/4cc23ed0-2de6-4c8c-8c0b-f344e2b24687","type":"EvidenceLine","calculatedScore":1,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/4cc23ed0-2de6-4c8c-8c0b-f344e2b24687_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/26168268","allele":{"id":"https://genegraph.clinicalgenome.org/r/b1dd1f45-553f-425b-a720-36f6adf69227"},"alleleOrigin":{"id":"cg:DeNovoAlleleOrigin"},"paternityMaternityConfirmed":"Yes","zygosity":{"id":"cg:Heterozygous"}},{"id":"https://genegraph.clinicalgenome.org/r/4cc23ed0-2de6-4c8c-8c0b-f344e2b24687_function_evidence_item","type":"VariantFunctionalImpactEvidence","dc:description":"Functional analysis in transfected HEK293 cells revealed impaired PP2A A and C subunit binding (Houge et al., 2015, PMID: 26168268; Oyama et al., 2023, PMID: 36216457).","functionalDataSupport":"Yes"}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":1},{"id":"https://genegraph.clinicalgenome.org/r/49c2f9f6-9a7b-46f3-814b-2a373e6b4c30","type":"EvidenceLine","calculatedScore":1,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/49c2f9f6-9a7b-46f3-814b-2a373e6b4c30_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/26168268","allele":{"id":"https://genegraph.clinicalgenome.org/r/b1dd1f45-553f-425b-a720-36f6adf69227"},"alleleOrigin":{"id":"cg:DeNovoAlleleOrigin"},"paternityMaternityConfirmed":"Yes","zygosity":{"id":"cg:Heterozygous"}},{"id":"https://genegraph.clinicalgenome.org/r/49c2f9f6-9a7b-46f3-814b-2a373e6b4c30_function_evidence_item","type":"VariantFunctionalImpactEvidence","dc:description":"Functional analysis in transfected HEK293 cells revealed impaired PP2A A and C subunit binding (Houge et al., 2015, PMID: 26168268; Oyama et al., 2023, PMID: 36216457).","functionalDataSupport":"Yes"}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":1},{"id":"https://genegraph.clinicalgenome.org/r/05017312-4db5-482d-abf6-eec0de85174c","type":"EvidenceLine","calculatedScore":1,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/05017312-4db5-482d-abf6-eec0de85174c_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/25972378","allele":{"id":"https://genegraph.clinicalgenome.org/r/3ca8b8ff-3597-4cd4-9191-2e00a9ec228e"},"alleleOrigin":{"id":"cg:DeNovoAlleleOrigin"},"paternityMaternityConfirmed":"Yes","zygosity":{"id":"cg:Heterozygous"}},{"id":"https://genegraph.clinicalgenome.org/r/05017312-4db5-482d-abf6-eec0de85174c_function_evidence_item","type":"VariantFunctionalImpactEvidence","dc:description":"Functional analysis in transfected HEK293 cells revealed impaired PP2A A and C subunit binding, and decreased substrate binding to liprin-α1 (encoded by PPFIA1) (Houge et al., 2015, PMID: 26168268; Oyama et al., 2023, PMID: 36216457).","functionalDataSupport":"Yes"}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":1},{"id":"https://genegraph.clinicalgenome.org/r/0973b26d-86db-44f4-a47c-b57e4e9aa42c","type":"EvidenceLine","calculatedScore":1,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/0973b26d-86db-44f4-a47c-b57e4e9aa42c_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/26576547","allele":{"id":"https://genegraph.clinicalgenome.org/r/90db29e3-cd1c-4f51-bf78-2194efc10d03"},"alleleOrigin":{"id":"cg:DeNovoAlleleOrigin"},"paternityMaternityConfirmed":"Yes","zygosity":{"id":"cg:Heterozygous"}},{"id":"https://genegraph.clinicalgenome.org/r/0973b26d-86db-44f4-a47c-b57e4e9aa42c_function_evidence_item","type":"VariantFunctionalImpactEvidence","dc:description":"Functional analysis in transfected HEK293 cells revealed decreased substrate binding to liprin-α1 (encoded by PPFIA1), with normal binding to PP2A A and C subunits (Oyama et al., 2023, PMID: 36216457).","functionalDataSupport":"Yes"}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":1},{"id":"https://genegraph.clinicalgenome.org/r/13600a36-7cd7-4168-89fc-01ae77bf2a70","type":"EvidenceLine","dc:description":"Patient also reported in Houge et al. (2015, PMID: 26168268) as Case 3.","calculatedScore":1,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/13600a36-7cd7-4168-89fc-01ae77bf2a70_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/25533962","allele":{"id":"https://genegraph.clinicalgenome.org/r/b1dd1f45-553f-425b-a720-36f6adf69227"},"alleleOrigin":{"id":"cg:DeNovoAlleleOrigin"},"paternityMaternityConfirmed":"Yes","zygosity":{"id":"cg:Heterozygous"}},{"id":"https://genegraph.clinicalgenome.org/r/13600a36-7cd7-4168-89fc-01ae77bf2a70_function_evidence_item","type":"VariantFunctionalImpactEvidence","dc:description":"Functional analysis in transfected HEK293 cells revealed impaired PP2A A and C subunit binding (Houge et al., 2015, PMID: 26168268; Oyama et al., 2023, PMID: 36216457). ","functionalDataSupport":"Yes"}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":1},{"id":"https://genegraph.clinicalgenome.org/r/d92b57e4-c095-4fe4-a758-4b4cd03c4fe6","type":"EvidenceLine","dc:description":"Patient also reported in Houge et al. (2015, PMID: 26168268) as Case 5.","calculatedScore":1,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/d92b57e4-c095-4fe4-a758-4b4cd03c4fe6_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/25533962","allele":{"id":"https://genegraph.clinicalgenome.org/r/b383e15a-60cd-4cde-8f22-ef3f19c46e1f","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_006245.4(PPP2R5D):c.602C>G (p.Pro201Arg)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA10575693"}},"alleleOrigin":{"id":"cg:DeNovoAlleleOrigin"},"paternityMaternityConfirmed":"Yes","zygosity":{"id":"cg:Heterozygous"}},{"id":"https://genegraph.clinicalgenome.org/r/d92b57e4-c095-4fe4-a758-4b4cd03c4fe6_function_evidence_item","type":"VariantFunctionalImpactEvidence","dc:description":"Functional analysis in transfected HEK293 cells revealed impaired PP2A A and C subunit binding (Houge et al., 2015, PMID: 26168268).","functionalDataSupport":"Yes"}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":1},{"id":"https://genegraph.clinicalgenome.org/r/24de430a-e8f7-450d-9086-cc5cd4617b9a","type":"EvidenceLine","calculatedScore":1,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/24de430a-e8f7-450d-9086-cc5cd4617b9a_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/26168268","allele":{"id":"https://genegraph.clinicalgenome.org/r/b1dd1f45-553f-425b-a720-36f6adf69227"},"alleleOrigin":{"id":"cg:DeNovoAlleleOrigin"},"paternityMaternityConfirmed":"Yes","zygosity":{"id":"cg:Heterozygous"}},{"id":"https://genegraph.clinicalgenome.org/r/24de430a-e8f7-450d-9086-cc5cd4617b9a_function_evidence_item","type":"VariantFunctionalImpactEvidence","dc:description":"Yes (Functional analysis in transfected HEK293 cells revealed impaired PP2A A and C subunit binding (Houge et al., 2015, PMID: 26168268; Oyama et al., 2023, PMID: 36216457).","functionalDataSupport":"Yes"}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":1},{"id":"https://genegraph.clinicalgenome.org/r/cc9c352c-2212-4233-96ac-4e7a86b9a3f4","type":"EvidenceLine","calculatedScore":1,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/cc9c352c-2212-4233-96ac-4e7a86b9a3f4_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/26168268","allele":{"id":"https://genegraph.clinicalgenome.org/r/3ca8b8ff-3597-4cd4-9191-2e00a9ec228e"},"alleleOrigin":{"id":"cg:DeNovoAlleleOrigin"},"paternityMaternityConfirmed":"Yes","zygosity":{"id":"cg:Heterozygous"}},{"id":"https://genegraph.clinicalgenome.org/r/cc9c352c-2212-4233-96ac-4e7a86b9a3f4_function_evidence_item","type":"VariantFunctionalImpactEvidence","dc:description":"Yes (Functional analysis in transfected HEK293 cells revealed impaired PP2A A and C subunit binding, and decreased substrate binding to liprin-α1 (encoded by PPFIA1) (Houge et al., 2015, PMID: 26168268; Oyama et al., 2023, PMID: 36216457).","functionalDataSupport":"Yes"}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":1},{"id":"https://genegraph.clinicalgenome.org/r/32030135-5d39-4396-b285-2a692c2f9bcc","type":"EvidenceLine","calculatedScore":0.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/32030135-5d39-4396-b285-2a692c2f9bcc_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/26168268","allele":{"id":"https://genegraph.clinicalgenome.org/r/c3c5b409-889a-4eee-90c7-a49e35c0f105","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_006245.4(PPP2R5D):c.157C>T (p.Pro53Ser)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA355020"}},"alleleOrigin":{"id":"cg:DeNovoAlleleOrigin"},"paternityMaternityConfirmed":"Yes","zygosity":{"id":"cg:Heterozygous"}},{"id":"https://genegraph.clinicalgenome.org/r/32030135-5d39-4396-b285-2a692c2f9bcc_function_evidence_item","type":"VariantFunctionalImpactEvidence","dc:description":"Functional analysis in transfected HEK293 cells revealed that the N-terminal p.Pro53Ser variant did not affect PP2A A and C subunit binding (Houge et al., 2015, PMID: 26168268).","functionalDataSupport":"No"}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":0.5},{"id":"https://genegraph.clinicalgenome.org/r/66cb536d-c5ff-4850-a218-d099c5c93b4c","type":"EvidenceLine","calculatedScore":1,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/66cb536d-c5ff-4850-a218-d099c5c93b4c_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/25972378","allele":{"id":"https://genegraph.clinicalgenome.org/r/b1dd1f45-553f-425b-a720-36f6adf69227"},"alleleOrigin":{"id":"cg:DeNovoAlleleOrigin"},"paternityMaternityConfirmed":"Yes","zygosity":{"id":"cg:Heterozygous"}},{"id":"https://genegraph.clinicalgenome.org/r/66cb536d-c5ff-4850-a218-d099c5c93b4c_function_evidence_item","type":"VariantFunctionalImpactEvidence","dc:description":"Functional analysis in transfected HEK293 cells revealed impaired PP2A A and C subunit binding (Houge et al., 2015, PMID: 26168268; Oyama et al., 2023, PMID: 36216457).)","functionalDataSupport":"Yes"}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":1},{"id":"https://genegraph.clinicalgenome.org/r/1dc19967-b38f-4f86-8b32-61761afb3d3f","type":"EvidenceLine","dc:description":"Inheritance unknown, but this is a recurrent pathogenic variant, so it was scored 1 point as in patients where the variant is de novo.","calculatedScore":0.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/1dc19967-b38f-4f86-8b32-61761afb3d3f_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/25972378","allele":{"id":"https://genegraph.clinicalgenome.org/r/3ca8b8ff-3597-4cd4-9191-2e00a9ec228e"},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"paternityMaternityConfirmed":"No","zygosity":{"id":"cg:Heterozygous"}},{"id":"https://genegraph.clinicalgenome.org/r/1dc19967-b38f-4f86-8b32-61761afb3d3f_function_evidence_item","type":"VariantFunctionalImpactEvidence","dc:description":"Functional analysis in transfected HEK293 cells revealed impaired PP2A A and C subunit binding, and decreased substrate binding to liprin-α1 (encoded by PPFIA1) (Houge et al., 2015, PMID: 26168268; Oyama et al., 2023, PMID: 36216457).","functionalDataSupport":"Yes"}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":1},{"id":"https://genegraph.clinicalgenome.org/r/cf78def6-c620-4766-9d38-db075ce145a3","type":"EvidenceLine","calculatedScore":1,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/cf78def6-c620-4766-9d38-db075ce145a3_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/26576547","allele":{"id":"https://genegraph.clinicalgenome.org/r/a10a9bd5-1ae8-4097-b2a1-f5253204f210","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_006245.4(PPP2R5D):c.589G>A (p.Glu197Lys)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA325485"}},"alleleOrigin":{"id":"cg:DeNovoAlleleOrigin"},"paternityMaternityConfirmed":"Yes","zygosity":{"id":"cg:Heterozygous"}},{"id":"https://genegraph.clinicalgenome.org/r/cf78def6-c620-4766-9d38-db075ce145a3_function_evidence_item","type":"VariantFunctionalImpactEvidence","dc:description":"Functional analysis in transfected HEK293 cells revealed decreased substrate binding to liprin-α1 (encoded by PPFIA1), with normal binding to PP2A A and C subunits (Oyama et al., 2023, PMID: 36216457).","functionalDataSupport":"Yes"}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":1},{"id":"https://genegraph.clinicalgenome.org/r/52fddcae-4c86-4005-b36e-52e19718edf6","type":"EvidenceLine","calculatedScore":1,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/52fddcae-4c86-4005-b36e-52e19718edf6_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/26576547","allele":{"id":"https://genegraph.clinicalgenome.org/r/b1dd1f45-553f-425b-a720-36f6adf69227"},"alleleOrigin":{"id":"cg:DeNovoAlleleOrigin"},"paternityMaternityConfirmed":"Yes","zygosity":{"id":"cg:Heterozygous"}},{"id":"https://genegraph.clinicalgenome.org/r/52fddcae-4c86-4005-b36e-52e19718edf6_function_evidence_item","type":"VariantFunctionalImpactEvidence","dc:description":"Functional analysis in transfected HEK293 cells revealed impaired PP2A A and C subunit binding (Houge et al., 2015, PMID: 26168268; Oyama et al., 2023, PMID: 36216457).","functionalDataSupport":"Yes"}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":1},{"id":"https://genegraph.clinicalgenome.org/r/ef5607d8-e7f4-4584-a0bf-e7815b66cac9","type":"EvidenceLine","calculatedScore":1,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/ef5607d8-e7f4-4584-a0bf-e7815b66cac9_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/26576547","allele":{"id":"https://genegraph.clinicalgenome.org/r/3ca8b8ff-3597-4cd4-9191-2e00a9ec228e"},"alleleOrigin":{"id":"cg:DeNovoAlleleOrigin"},"paternityMaternityConfirmed":"Yes","zygosity":{"id":"cg:Heterozygous"}},{"id":"https://genegraph.clinicalgenome.org/r/ef5607d8-e7f4-4584-a0bf-e7815b66cac9_function_evidence_item","type":"VariantFunctionalImpactEvidence","dc:description":"Functional analysis in transfected HEK293 cells revealed impaired PP2A A and C subunit binding, and decreased substrate binding to liprin-α1 (encoded by PPFIA1) (Houge et al., 2015, PMID: 26168268; Oyama et al., 2023, PMID: 36216457).","functionalDataSupport":"Yes"}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":1},{"id":"https://genegraph.clinicalgenome.org/r/408db2eb-b395-41c9-b332-eb2adae9ff39","type":"EvidenceLine","calculatedScore":1,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/408db2eb-b395-41c9-b332-eb2adae9ff39_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/26168268","allele":{"id":"https://genegraph.clinicalgenome.org/r/fd9ba972-e78d-424d-b0c6-29127e98c34b","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_006245.4(PPP2R5D):c.619T>A (p.Trp207Arg)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA358858"}},"alleleOrigin":{"id":"cg:DeNovoAlleleOrigin"},"paternityMaternityConfirmed":"Yes","zygosity":{"id":"cg:Heterozygous"}},{"id":"https://genegraph.clinicalgenome.org/r/408db2eb-b395-41c9-b332-eb2adae9ff39_function_evidence_item","type":"VariantFunctionalImpactEvidence","dc:description":"Functional analysis in transfected HEK293 cells revealed impaired PP2A A and C subunit binding (Houge et al., 2015, PMID: 26168268; Oyama et al., 2023, PMID: 36216457).","functionalDataSupport":"Yes"}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":1}],"specifiedBy":"GeneValidityOverallGeneticEvidenceCriteria","strengthScore":12},{"id":"https://genegraph.clinicalgenome.org/r/4b43ff91-1ea4-475b-97d9-6fbda924ea16_experimental_evidence_line","type":"EvidenceLine","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/4b43ff91-1ea4-475b-97d9-6fbda924ea16_functional_evidence_line","type":"EvidenceLine","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/165979bd-4de7-484a-ba6e-1a35c055e787","type":"EvidenceLine","calculatedScore":0.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/011d0934-fd2b-4641-ba9f-e0f1b846db25","type":"Finding","dc:description":"The PP2A holoenzymes are comprised of three subunits: a catalytic C subunit, a scaffolding A subunit, and a regulatory B subunit, encoded by 19 genes. The protein encoded by the PPP2R5D gene, the B56δ regulatory subunit, interacts with the scaffold Aα subunit encoded by PPP2R1A, and the catalytic Cα subunit encoded by PPP2CA. Missense variants in PPP2R5D result in A/C subunit binding defects. Pathogenic variants in PPP2R1A and PPP2CA are associated with neurodevelopmental disorders.","dc:source":"https://pubmed.ncbi.nlm.nih.gov/36216457","rdfs:label":"Interaction PP2A subunits","demonstrates":{"id":"obo:MI_0915"}}],"specifiedBy":"GeneValidityProteinInteractionCriteria","strengthScore":0.5},{"id":"https://genegraph.clinicalgenome.org/r/2583e2a8-81ab-4087-a774-19ce6f7d6f1e","type":"EvidenceLine","calculatedScore":0.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/3cba4d12-6a7a-496e-a71e-05a1b2bda08c","type":"Finding","dc:description":"Pathogenic variants in other members of the protein phosphatase 2A (PP2A) gene family, PPP2R1A, PPP2CA and PPP2R5C, also cause neurodevelopmental disorders with overlapping phenotypes.","dc:source":"https://pubmed.ncbi.nlm.nih.gov/34241636","rdfs:label":"PP2A gene family","demonstrates":{"id":"cg:BiochemicalFunctionA"}}],"specifiedBy":"GeneValidityBiochemicalFunctionCriteria","strengthScore":0.5}],"specifiedBy":"GeneValidityOverallFunctionalEvidenceCriteria","strengthScore":1},{"id":"https://genegraph.clinicalgenome.org/r/4b43ff91-1ea4-475b-97d9-6fbda924ea16_model_rescue_evidence_line","type":"EvidenceLine","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/cc787400-430f-4c82-a376-119034329a3a","type":"EvidenceLine","dc:description":"These mice are homozygous for null alleles, whereas affected individuals are heterozygous for missense variants. No cognitive deficits were observed in this mouse model.","calculatedScore":2,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/5e133d06-7cae-4f5a-8ba1-72671d0edc99","type":"Finding","dc:description":"Ppp2r5d-null mice developed a progressive increase in phosphorylated tau in the brainstem and spinal cord compared to wildtype mice. These changes were associated with progressive sensorimotor deficits, but not cognitive dysfunction.\n","dc:source":"https://pubmed.ncbi.nlm.nih.gov/21482799","rdfs:label":"Ppp2r5d null mice","demonstrates":{"id":"cg:ProteinAlterationDisruptsOrganismFunction"}}],"specifiedBy":"GeneValidityNonHumanModelOrganismCriteria","strengthScore":0}],"specifiedBy":"GeneValidityOverallModelAndRescueEvidenceCriteria","strengthScore":0}],"specifiedBy":"GeneValidityOverallExperimentalEvidenceCriteria","strengthScore":1}],"evidenceStrength":"Definitive","sequence":11945,"specifiedBy":"GeneValidityCriteria11","strengthScore":13,"subject":{"id":"https://genegraph.clinicalgenome.org/r/g1B4JHmes1Q","type":"GeneValidityProposition","disease":"obo:MONDO_0100038","gene":"hgnc:9312","modeOfInheritance":"obo:HP_0000006"},"version":"2.2","websiteLegacyID":"https://genegraph.clinicalgenome.org/r/assertion_4b43ff91-1ea4-475b-97d9-6fbda924ea16-","@context":{"@vocab":"https://genegraph.clinicalgenome.org/terms/","id":"@id","type":"@type","cg":"https://genegraph.clinicalgenome.org/terms/","dc":"http://purl.org/dc/terms/","obo":"http://purl.obolibrary.org/obo/","hgnc":"https://identifiers.org/hgnc:","rdfs":"http://www.w3.org/2000/01/rdf-schema#","cggv":"https://genegraph.clinicalgenome.org/r/gci/","evidenceStrength":{"@type":"@vocab"},"calculatedEvidenceStrength":{"@type":"@vocab"},"computedEvidenceStrength":{"@type":"@vocab"},"specifiedBy":{"@type":"@vocab"},"evidence":{"@container":"@set"},"disease":{"@type":"@vocab"},"gene":{"@type":"@vocab"},"phenotypes":{"@type":"@id"},"agent":{"@type":"@id"},"role":{"@type":"@vocab"},"modeOfInheritance":{"@type":"@vocab"},"sex":{"@type":"@vocab"},"direction":{"@type":"@vocab"},"ageType":{"@type":"@vocab"},"ageUnit":{"@type":"@vocab"},"dc:source":{"@type":"@id"},"curationReasons":{"@type":"@vocab","@container":"@set"},"GCISnapshot":{"@type":"@id"},"dc:isVersionOf":{"@type":"@id"},"websiteLegacyID":{"@type":"@id"}}}